Related Experiment Video
Updated: Aug 29, 2026

How to Obtain Reliable Visual Event-related Potentials in Newborns
Published on: October 24, 2019
Multifocal VEP in children: its maturation and clinical application
C Balachandran1, A I Klistorner, F Billson
1Save Sight Institute, Department of Ophthalmology, University of Sydney, Macquarie Street, PO Box 1614, Sydney 2001, Australia. Chandra@eye.usyd.edu.au
Insights
Multifocal visual evoked potentials (VEP) mature with age in children, with amplitude increasing significantly between 11-13 years and latency stabilizing by 13. This objective test aids in diagnosing visual pathway diseases in children.
Area of Science:
- Ophthalmology
- Neuroscience
- Pediatrics
Background:
- Assessing visual pathway maturation in children is crucial for diagnosing optic nerve diseases.
- Multifocal visual evoked potentials (mfVEP) offer an objective method to evaluate visual function.
Observation:
- mfVEP amplitude shows a sigmoid relationship with age, with significant development between 11-13 years.
- Latency decreases with age, stabilizing around 13 years.
- Scaled mfVEP amplitude demonstrates reduced variability and age-related changes across tested eccentricities.
Findings:
- The study established normative mfVEP maturation data in 70 healthy children aged 5-16 years.
- mfVEP successfully identified visual field defects in children with optic nerve glioma and congenital glaucoma.
- Age-related changes in mfVEP amplitude and latency provide a developmental timeline for the visual pathway.
Implications:
- mfVEP perimetry is a valuable, objective tool for diagnosing visual field deficits in pediatric patients.
- This technique can document visual pathway abnormalities in children as young as 5 years old.
- mfVEP can aid in early diagnosis and management of optic pathway diseases before subjective testing is feasible.
Aim:
To study the maturation of multifocal visual evoked potentials (multifocal VEP) in normal children between the ages of 5 and 16 years and to apply the results clinically in selected cases to the diagnosis of optic pathway diseases.
Method:
70 normal children were recruited from the community and multifocal VEP (Accumap ObjectiVision, Sydney, Australia) was recorded. The waveform of the evoked responses, the latency and amplitude were analysed. Using these data, an age matched comparison was made with three children with advanced optic nerve disease; two had optic nerve glioma and one had congenital glaucoma.
Results:
The full field amplitude did not correlate with age and varied greatly within each age group (coefficient of variability 28%). When scaled with respect to the background electroencephalogram the intra-age group variability decreased to 15% and a sigmoid relation was found between amplitude and age. The scaled amplitude remained largely unchanged till 11 years, between 11 and 13 years there was a rapid increase (40%), and remained stable thereafter. This relation was seen at all eccentricities tested. The latency decreased gradually with age and plateaued at 13 years. In the three children with vision abnormalities this test was able to detect scotomas consistent with their condition.
Conclusion:
Multifocal VEP perimetry shows an age related maturation in the visual pathway, characterised by distinctive timeframe of development for amplitude and latency. It can be performed by children as young as 5 years of age and holds promise as a diagnostic test capable of documenting children's visual fields objectively, even before they are able to perform subjective field tests.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Ophthalmic Drug Delivery Systems
